You've found a trial. The eligibility criteria fit. The research coordinator has called. Now you're looking at a 20-page informed consent document written in language that feels like it was designed to obscure rather than clarify.

This is the moment where many parents sign without fully understanding what they've agreed to. The consent process is complex, the stakes feel high, and the pressure to say yes can feel overwhelming when you're looking for answers.

Here's what to ask before you sign. These aren't screening questions designed to filter out trials. They're the framework for understanding what participation involves, what risks you're accepting, and what rights you retain throughout.

Questions About Safety and Risk

What are the specific risks of this trial compared to standard care?

The consent form will list potential side effects. What you need to know is how those risks compare to what your child would face without the trial. If the trial involves a new medication, ask what adverse events have been reported in earlier phases. If it's a device trial, ask about failure rates or complications in previous testing.

Push for specifics. "Rare complications" means different things in different contexts. A 2% complication rate might be acceptable for a treatment addressing a life-threatening condition. It might not be acceptable for a study testing a quality-of-life intervention.

How invasive are the trial procedures compared to what my child is already doing?

Some trials require only what your child is already receiving: standard monitoring, bloodwork, imaging. Others involve additional procedures: biopsies, spinal taps, experimental devices. The FDA recommends asking explicitly how much more invasive participation will be than the care your child would receive otherwise.

If the trial requires procedures your child wouldn't otherwise need, ask why. What is being measured, and is that measurement essential to the research question? Some parents assume research procedures are medically necessary for their child's care. They aren't always.

What side effects should I watch for, and what's the protocol if they occur?

You need two things here: a clear list of side effects the research team is monitoring for, and specific instructions on what to do if those side effects appear. Who do you call? What timeframe matters? Is there an after-hours contact, or do you go to the emergency room?

Write this down. The consent form may contain this information buried in section seven of twelve. You need it at the front of your notes.

What happens if my child has a serious adverse event during the trial?

Who covers the medical costs if something goes wrong? This varies by trial sponsor and institution. Some trials cover all costs related to trial participation, including complications. Others cover only direct research costs, leaving families responsible for treatment of adverse events.

Ask about insurance coverage. Ask what happens if your child needs care beyond what the trial anticipated. Get this in writing.

Questions About What Participation Involves

How often will my child need to visit the trial site, and how long will each visit take?

Trials can require weekly visits or monthly check-ins. Some visits take an hour. Others take a full day. If the trial site is an hour away, a weekly requirement means significant time away from school, work, or other therapies.

Calculate the total time commitment before you agree. Factor in travel, wait times, and whether your child will need to miss school or cancel existing appointments.

What tests or procedures will my child undergo, and what's the timeline?

Some trials involve baseline testing, ongoing monitoring, and end-of-trial assessments. Ask for the schedule. If your child is already overwhelmed by medical appointments, adding trial visits on top of standard care may not be sustainable.

Will my child receive the treatment being studied, or is there a placebo group?

Placebo-controlled trials are standard in research, but not all parents realize their child might receive a placebo instead of the experimental treatment. If the trial is randomized, ask what the odds are of being assigned to each group.

Ask what happens if your child is in the placebo group and the treatment proves effective. Will they have access to the treatment after the trial ends?

What happens when the trial ends?

If the treatment works, does your child continue receiving it? Some trials provide ongoing access. Others end abruptly, leaving families to figure out how to continue a therapy that's not yet FDA-approved or commercially available.

If your child benefits from the treatment, ask now how you'll maintain access after the study closes.

Questions About Consent and Withdrawal Rights

Can I withdraw my child from the trial at any time?

Yes. Participation is voluntary at every stage. You can withdraw without giving a reason, and your child's standard medical care cannot be affected by that decision.

Many parents don't know this. They assume that enrolling is a binding commitment, or that leaving the trial means abandoning the relationship with the research team or clinic. It doesn't. You're allowed to leave, and the decision to pull out is one you're entitled to make without justification.

If I withdraw, what happens to the data already collected?

In most cases, data collected before withdrawal remains part of the study. Ask whether this applies, and whether there are any exceptions. Some parents prefer to withdraw data entirely if they leave a trial early. Many trials don't allow this, but it's worth asking.

What's the process for pausing participation if my child gets sick or needs a break?

Life doesn't stop during a trial. Your child might catch the flu, need surgery unrelated to the trial, or simply need time away from medical appointments. Ask whether temporary pauses are allowed and what the protocol is for resuming.

Questions About Compensation and Logistics

Will my family be compensated for time and travel?

Some trials cover parking, mileage, or meals. Others provide stipends for participation. Some offer nothing. Ask what's provided and when payments are issued.

If compensation is tied to completing the full trial, that creates an incentive to stay enrolled even if participation becomes difficult. Be aware of that dynamic when making your decision.

What support is available if my child needs accommodations during the trial?

If your child uses a wheelchair, ask whether the facility is accessible. If they're nonverbal, ask whether the research team has experience working with AAC users. If they have sensory sensitivities, ask what accommodations are available during procedures.

The best trials plan for this. The ones that don't may not be a good fit.

Questions About the Research Team

Who will be my primary contact throughout the trial?

You need one person you can reach with questions, concerns, or logistical issues. Ask for their contact information and what hours they're available.

What's your experience working with children who have my child's condition?

A trial testing a new autism therapy should be staffed by researchers who understand autism. A cerebral palsy trial should involve people who know how CP affects mobility, communication, and daily function.

If the research team doesn't have that expertise, ask how they plan to address it.

How will you communicate results to me?

Some trials share interim findings with participants. Others don't release results until the study is published, which can take years. Ask when and how you'll learn what the trial discovered.

What to Do With These Questions

Bring this list to your enrollment conversation. Take notes. If the research coordinator can't answer a question, ask who can. If an answer doesn't make sense, ask again.

You're not obligated to enroll. The decision to participate is yours, and it should be based on a clear understanding of what you're agreeing to. If that understanding isn't there yet, schedule a follow-up call.

The consent form is legally binding, but it's not the end of the conversation. These questions are. Use them.